As medicine becomes more and more personalized, this system becomes less and less tenable. There may come a time when all insured people must be genotyped. Those with favorable genotypes will pay less for insurance, while those with unfavorable genotypes will pay more. The lucky will be luckier and the unlucky will be unluckier.
